伊朗正经历严重的医疗危机，药物价格大幅上涨且供应短缺，使许多患者被迫延迟或放弃治疗。1一名70岁乳腺癌患者的单次化疗费用约1亿伊朗里亚尔（约530美元或450欧元），相当于伊朗最低月工资1660万里亚尔的六倍。1某制药公司宣布旗下82种产品涨价，平均涨幅约120%，从18万里亚尔上升至39万里亚尔；其中个别药物涨幅更为惊人，多奈哌齐上升543%，克拉霉素上升308%，阿莫西林上升115%。1诊疗中常用的NovoRapid胰岛素笔月费用从保险报销后的28万里亚尔跳升至110万里亚尔。1
药物短缺问题同样严峻。1伊朗议会卫生委员会发言人指出约43种药物处于"临界短缺"状态，近1000种药物存在不同程度短缺。1患者自付医疗费用比例从预期的30%上升至70%以上。1伊朗食品药品监督管理局主任表示，战争后货币转账大幅放缓，曾几乎停止了1至2个月。1伊朗政府指责货币贬值、国际支付困难、美国制裁和战争的经济影响是危机根源。1伊朗央行行长称前五个月的医药外汇分配比去年同期增加30%。1
Iran is experiencing a severe healthcare crisis as medication prices have skyrocketed while drug supplies dwindle, leaving many patients unable to afford necessary treatment.1 A single chemotherapy session costs approximately 100 million Iranian rials, equivalent to about $530 or €450, which is six times the country's minimum monthly wage of 16.6 million rials.1 The situation has forced numerous patients to delay or abandon medical care due to cost constraints.
Pharmaceutical price increases have been dramatic across the board.1 One drug manufacturer announced price hikes for 82 products, averaging around 120 percent, with prices rising from 180,000 rials to 390,000 rials per unit.1 Some medications experienced even steeper increases: donepezil climbed 543 percent, clarithromycin rose 308 percent, and amoxicillin increased 115 percent.1 Insulin therapy has also become increasingly unaffordable, with NovoRapid insulin pens jumping from 280,000 rials to 1.1 million rials monthly after insurance coverage.1 The oncology drug Keytruda's Iranian version costs approximately 70 million rials—more than four times the monthly minimum wage—while its Indian counterpart reaches 300 million rials.1
The shortage situation is equally alarming.1 According to Iran's parliamentary health committee spokesperson, approximately 43 medicines are in "critical shortage," while nearly 1,000 drugs face varying degrees of supply constraints.1 Patient out-of-pocket expenses have surged from an anticipated 30 percent to over 70 percent of treatment costs.1 Iranian officials attribute the crisis to currency depreciation, international payment difficulties, American sanctions, and economic impacts from regional conflicts.1 The head of Iran's Food and Drug Administration noted that since the onset of war, international currency transfers have significantly slowed, nearly halting for one to two months at one point.1
评论
还没有评论，欢迎留下第一条。